Why Testing for Norfentanyl Matters

August 5, 2026

Closing a Gap in Fentanyl Urine Drug Screening

By the Precision Test Supply Clinical Support Team | 20+ years of experience in laboratory and addiction medicine testing workflows

Fentanyl testing has become a standard part of urine drug screening for sober living homes, addiction treatment programs, behavioral health providers, pain management practices, and probation or community supervision programs.

But there is an important question many organizations overlook:

Does your urine drug test screen for both fentanyl and norfentanyl?

Fentanyl is metabolized by the body into norfentanyl, its primary metabolite. Because norfentanyl may remain detectable in urine after fentanyl concentrations decline, testing for both markers can provide a broader picture of recent fentanyl exposure than testing for fentanyl alone — and published clinical data backs that up with real numbers, not just theory.

Key Takeaway: A fentanyl-only urine drug test screens for the parent drug. A test that includes both fentanyl and norfentanyl provides broader marker coverage and, according to clinical research, can identify evidence of fentanyl exposure that a fentanyl-only test misses in a meaningful share of cases.

What Is Norfentanyl?

Norfentanyl is the primary metabolite the liver produces when it processes fentanyl. The conversion happens through an enzyme called CYP3A4 in a process known as N-dealkylation. Roughly 75% of a fentanyl dose is metabolized this way, and less than 10% of the original drug is ever excreted unchanged — meaning most of the evidence of use ends up as norfentanyl, not fentanyl itself.

Fentanyl and norfentanyl do not appear in urine at the same concentrations or clear the body at the same rate. In some cases, fentanyl concentrations decline below a test's cutoff while norfentanyl remains detectable. Published research illustrates just how large that gap can be:

• One postoperative clinical study found fentanyl undetectable in urine by 72 hours, while norfentanyl was still present in all patients at 48 hours and in more than half of patients at 96 hours.

• Pharmacokinetic data from chronic-use populations shows fentanyl clearing in roughly 7 days on average, compared to approximately 13 days on average for norfentanyl — with some individual cases extending well beyond that.

• Hair-testing research (a different specimen type, included here for context) has detected fentanyl and norfentanyl for up to 90 days post-exposure, reinforcing how much longer the metabolite persists compared to the parent compound.

Detection times still vary based on the amount and frequency of use, individual metabolism, urine concentration, the sensitivity and cutoff of the test, and other biological factors. No urine drug test can guarantee detection of every instance of use — but the research consistently shows norfentanyl outlasting fentanyl, often by days.

Why Fentanyl-Only Testing May Leave a Gap

A fentanyl-only urine drug test is designed to identify fentanyl according to that test's specific cutoff. If fentanyl concentrations decline below the cutoff, the result may be negative even when norfentanyl is still present. That does not mean the test failed — it means the test was built to screen for the parent drug and was never designed to separately detect its metabolite.

This is not a theoretical gap. A 2024 clinical study comparing immunoassay performance against LC-MS/MS confirmation found that roughly 30% of positive specimens had detectable norfentanyl while fentanyl itself measured below the detection threshold. Among the specimens positive only for the metabolite, more than half would have returned a false negative on an assay not sensitive to norfentanyl.

In practical terms: in a meaningful share of real-world specimens, a fentanyl-only screen would have cleared a sample that a dual fentanyl-and-norfentanyl screen correctly flagged. Adding norfentanyl detection can help organizations:

• Screen for both fentanyl and its primary metabolite in a single test

• Obtain a broader picture of recent fentanyl exposure

• Reduce the impact that testing timing has on available screening information

• Avoid adding a separate fentanyl test strip or collecting an additional specimen

• Keep testing simple with one all-in-one drug test cup

For programs that test residents, patients, or participants on a scheduled basis rather than continuously, including both markers may provide more useful screening information between testing dates.

Which Programs May Benefit From Fentanyl and Norfentanyl Testing?

Sober Living Homes and Recovery Residences

Sober living homes and recovery residences often rely on scheduled or random drug testing to support accountability and maintain a safe recovery environment. Because testing does not happen continuously, the timing of a collection affects what gets detected. A test that screens for both fentanyl and norfentanyl may provide broader coverage than a fentanyl-only test in the days between scheduled tests.

Addiction Treatment and Behavioral Health Programs

Outpatient treatment programs, behavioral health providers, and MAT/MOUD programs use urine drug screening to support treatment planning, monitor progress, and guide clinical conversations. Including both fentanyl and norfentanyl in a testing panel can provide clinical teams with additional screening information without changing the collection process or adding a separate routine test.

Pain Management Practices

Pain management providers use urine drug testing to monitor prescribed medications and identify unexpected substances. A multi-panel cup that includes fentanyl and norfentanyl provides broader screening coverage while keeping the testing process efficient. Unexpected results should be evaluated according to the practice's clinical protocols and, when appropriate, confirmed through laboratory testing.

Probation, Court-Ordered, and Community Supervision Programs

Testing schedules in probation, diversion, and other community supervision programs are often set by program requirements rather than an individual's actual pattern of use. Including both fentanyl and norfentanyl can provide additional screening information when collection opportunities are limited. Presumptive positive results used for legal or other high-stakes decisions should still be confirmed using an appropriate laboratory method.

BioSieve 14-Panel Drug Test Cup With FTY + NFYT

Precision Test Supply offers the BioSieve 14-Panel Multi-Drug Test Cup with FTY + NFYT, a CLIA-waived urine drug screening cup designed to detect both fentanyl (FTY) and norfentanyl (NFYT) in a single urine collection.

It's also one of the few CLIA-waived cups on the market built with both markers included — most fentanyl-inclusive panels stop at the parent compound.

Product Specifications

• Fentanyl cutoff: 1 ng/mL

• Norfentanyl cutoff: 5 ng/mL

• Results available in approximately 5 minutes; read within a 10-minute window

• Specimen type: Urine

• Regulatory status: FDA-cleared and CLIA-waived

• Package size: 25 tests per box

• All-in-one, one-step format — no lab equipment or specialized training required

For context, published federal guidance on laboratory testing cites initial fentanyl cutoffs generally ranging from 0.5–2 ng/mL, with norfentanyl confirmatory cutoffs ranging from 0.5–5 ng/mL depending on the lab and assay. The BioSieve cup's 1 ng/mL fentanyl and 5 ng/mL norfentanyl cutoffs fall squarely within that clinically accepted range.

What Does the BioSieve 14-Panel Cup Test For?

• AMP — Amphetamine

• BAR — Barbiturates

• BUP — Buprenorphine

• BZO — Benzodiazepines

• COC — Cocaine

• FTY — Fentanyl

• MDMA — Ecstasy/MDMA

• MET — Methamphetamine

• MOP — Morphine/Opiates

• MTD — Methadone

• NFYT — Norfentanyl

• OXY — Oxycodone

• PCP — Phencyclidine

• THC — Marijuana

Why the FTY + NFYT Combination Matters

Many rapid urine drug tests include fentanyl but do not separately screen for norfentanyl. The BioSieve 14-Panel Cup includes both markers in the same test, which means your organization gets broader fentanyl-related screening coverage without requiring a separate fentanyl test strip, an additional urine collection, a second point-of-care test, or a routine laboratory send-out.

Shop the BioSieve 14-Panel Drug Test Cup with FTY + NFYT: precisiontestsupply.com/products/biosieve-multi-drugs-14-panel-fty-nfyt-clia-waived

Fentanyl-Only vs. Fentanyl + Norfentanyl Testing

Test Configuration	Detects Fentanyl	Detects Norfentanyl	Effective Screening Coverage
Standard multi-panel cup (no fentanyl)	No	No	Does not screen for fentanyl at all
Fentanyl-only test	Yes	No	Screens for the parent drug only; may miss cases where fentanyl has cleared but norfentanyl remains
BioSieve 14-Panel Cup with FTY + NFYT	Yes	Yes	Screens for fentanyl and its primary metabolite in one urine collection

The advantage of a dual FTY/NFYT panel is not that it guarantees detection of every instance of fentanyl use — no test can promise that. Rather, published research shows it meaningfully narrows the gap that a fentanyl-only test leaves open, all within one convenient, CLIA-waived urine collection.

Important: Rapid Drug Tests Are Screening Tools

Rapid urine drug test cups provide presumptive screening results. They are not designed to determine the exact timing, amount, or pattern of substance use. When a positive result will be used for legal, employment, custody, disciplinary, or other high-stakes decisions, confirmation by an appropriate laboratory method (typically LC-MS/MS) should be considered or required under the organization's policies and applicable regulations.

A positive fentanyl or norfentanyl result should be interpreted within the full clinical or program context. Detection may be influenced by individual metabolism, frequency of use, urine concentration, test cutoff, and other factors.

Frequently Asked Questions

What is norfentanyl?

Norfentanyl is the primary metabolite produced when the liver processes fentanyl through an enzyme called CYP3A4. It is inactive but frequently remains detectable in urine after fentanyl concentrations have declined.

Why test for norfentanyl in addition to fentanyl?

Because fentanyl and norfentanyl clear the body at different rates. Clinical studies have found norfentanyl detectable in urine well after fentanyl itself has fallen below a test's cutoff — in one postoperative study, norfentanyl was still present in over half of patients at 96 hours, after fentanyl was already undetectable.

Can a fentanyl-only test miss norfentanyl?

Yes. A fentanyl-only test is built to detect fentanyl at its own cutoff and is not designed to separately identify norfentanyl. A 2024 clinical study found that roughly 30% of positive specimens had detectable norfentanyl with fentanyl below the threshold — cases a fentanyl-only assay could miss.

How long are fentanyl and norfentanyl detectable in urine?

Fentanyl is typically detectable for approximately 24–72 hours after use. Norfentanyl has been shown in clinical studies to remain detectable well beyond that, and pharmacokinetic data from chronic-use populations shows it persisting roughly twice as long as fentanyl on average.

What are the BioSieve FTY and NFYT cutoff levels?

The BioSieve 14-Panel Drug Test Cup uses a 1 ng/mL cutoff for fentanyl and a 5 ng/mL cutoff for norfentanyl, consistent with the cutoff ranges cited in federal laboratory testing guidance.

Is the BioSieve 14-Panel Cup CLIA-waived?

Yes. The BioSieve 14-Panel Drug Test Cup with FTY + NFYT is FDA-cleared and CLIA-waived.

How quickly are BioSieve test results available?

Results are available in approximately 5 minutes and should be read within the specified 10-minute read window.

Is a positive fentanyl or norfentanyl result conclusive?

No. Rapid urine drug tests provide presumptive screening results. Confirmation testing may be appropriate or required when results will be used for high-stakes clinical, legal, employment, or program decisions.

Choose a Drug Test That Provides Broader Fentanyl Screening

If your organization is already testing for fentanyl, it may be worth reviewing whether your current panel also screens for norfentanyl — the research shows that gap is more common than most programs realize.

The BioSieve 14-Panel Drug Test Cup with FTY + NFYT combines:

• Fentanyl detection at a 1 ng/mL cutoff

• Norfentanyl detection at a 5 ng/mL cutoff

• 14-panel drug screening

• Results in approximately 5 minutes

• FDA-cleared and CLIA-waived testing

• A convenient, all-in-one urine drug test cup

• 25 tests per box